That's definitely not the case. I've worked in the UK on two health platform things, and the US market was by far the only one that could sustain normal prices.

That's definitely not the case. I've worked in the UK on two health platform things, and the US market was by far the only one that could sustain normal prices. And the UK buys US software (EPIC/Cerner, for example) from the US. It's not localised at all. There aren't that many systems. Plenty of countries use the FDA's rules, and many standards are relatively global.